Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

Immunotherapy (Checkpoint Inhibitor) (26)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Envafolimab	Anti-PD-1 mAb	Both (Solid & Hematologic)
Molecule Envafolimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Balstilimab	Anti-PD-1 mAb	Both (Solid & Hematologic)
Molecule Balstilimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Pucotenlimab	Anti-PD-1 mAb	Both (Solid & Hematologic)
Molecule Pucotenlimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Adebrelimab	Anti-PD-1 mAb	Both (Solid & Hematologic)
Molecule Adebrelimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Atezolizumab	Anti-PD-L1 mAb	Solid Tumour
Molecule Atezolizumab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-PD-L1 mAb
Durvalumab	Anti-PD-L1 mAb	Solid Tumour
Molecule Durvalumab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-PD-L1 mAb
Avelumab	Anti-PD-L1 mAb	Solid Tumour
Molecule Avelumab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-PD-L1 mAb
Ipilimumab	Anti-CTLA-4 mAb	Solid Tumour
Molecule Ipilimumab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-CTLA-4 mAb
Tremelimumab	Anti-CTLA-4 mAb	Solid Tumour
Molecule Tremelimumab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-CTLA-4 mAb
Zalifrelimab	Anti-CTLA-4 mAb	Solid Tumour
Molecule Zalifrelimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-CTLA-4 mAb
Botensilimab	Anti-CTLA-4 mAb	Solid Tumour
Molecule Botensilimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-CTLA-4 mAb
Relatlimab	Anti-LAG-3 mAb	Solid Tumour
Molecule Relatlimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-LAG-3 mAb

Envafolimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Balstilimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Pucotenlimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Adebrelimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Atezolizumab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-PD-L1 mAb
Durvalumab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-PD-L1 mAb
Avelumab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-PD-L1 mAb
Ipilimumab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-CTLA-4 mAb
Tremelimumab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-CTLA-4 mAb
Zalifrelimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-CTLA-4 mAb
Botensilimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-CTLA-4 mAb
Relatlimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Solid Tumour Drug Class / Mechanism Anti-LAG-3 mAb

‹ 1 2 3 ›

Product Range

Company

Global Network

Products

Envafolimab

Balstilimab

Pucotenlimab

Adebrelimab

Atezolizumab

Durvalumab

Avelumab

Ipilimumab

Tremelimumab

Zalifrelimab

Botensilimab

Relatlimab